Articles by Adeline Siew, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Adeline Siew, PhD

Nanosimilars and follow-on nanomedicines

Stefan Muhlebach explains why non-biological complex drugs (NBCDs) cannot be assessed using the standard generic or biosimilar approaches.
Mar 2, 2014

With nanomedicines on the rise, a new class of non-biological complex drugs (NBCDs), which include nanosimilars, has emerged. As drug regulators are faced with the challenge of defining a framework to ensure the safe introduction of the follow-on nano-therapeutics, Stefan Muhlebach explains why NBCDs cannot be assessed using the standard generic or biosimilar approaches.

Pulmonary Drug Delivery—Particle Engineering for Inhaled Therapeutics

Industry experts discuss the various factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.
Feb 2, 2014

Experts discuss factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.

Can Pharma Defy Gravity at the Patent Cliff?

Formulation strategies for product lifecycle optimization.
Dec 11, 2013

Formulation strategies for product lifecycle optimization.

Can Pharma Defy Gravity at the Patent Cliff?

Formulation strategies for product lifecycle optimization.
Nov 2, 2013

Pharmaceutical companies are using formulation strategies as a lifecycle management tool to maximize product value and preserve their revenue streams.

New Single-Use Bioreactor Technology Emphasizes Ease-of-Use and Intelligent Process Control

An updated bioreactor based on rocking technology has more advanced controls but is easier for biopharmaceutical manufacturers to use.
Oct 23, 2013

An updated bioreactor based on rocking technology has more advanced controls but is easier for biopharmaceutical manufacturers to use.

New Technology Enables Integrated Chromatographic Separation and Mass Detection

Mass detection at the push of a button could change the way many laboratories carry out their chromatographic analysis.
Oct 23, 2013

Mass detection at the push of a button could change the way many laboratories carry out their chromatographic analysis.

Solving the Insoluble

Oct 23, 2013

PharmTech spoke with Dow about innovations in polymers to address poor solubility.

Science-Based Technical Report Being Developed to Ensure Effective Use of Blow-Fill-Seal Technology

The Parenteral Drug Association has established a task force to develop a peer- and regulatory agency-reviewed Technical Report that will serve as a science-based industry reference document.
Oct 23, 2013

The Parenteral Drug Association has established a task force to develop a peer- and regulatory agency-reviewed Technical Report that will serve as a science-based industry reference document.

Unlocking the True Potential of Antibody Drug Conjugates

The success of Adcetris and Kadcyla is paving the way for more antibody drug conjugates to enter the market, especially in the treatment of solid tumors.
Oct 18, 2013

The success of Adcetris and Kadcyla is paving the way for more antibody drug conjugates to enter the market, especially in the treatment of solid tumors.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here